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Lipopolysaccharide-activated macrophages rapidly synthesize
and secrete tumor necrosis factor  (TNF) to prime the immune
system. Surface delivery of membrane carrying newly synthesized
TNF is controlled and limited by the level of solubleN-ethylmale-
imide-sensitive factor attachment protein receptor (SNARE) pro-
teins syntaxin 4 and SNAP-23. Many functions in immune cells are
coordinated from lipid rafts in the plasmamembrane, andwe inves-
tigated a possible role for lipid rafts in TNF trafficking and secre-
tion. TNF surface delivery and secretion were found to be choles-
terol-dependent. Upon macrophage activation, syntaxin 4 was
recruited to cholesterol-dependent lipid rafts, whereas its regula-
tory protein, Munc18c, was excluded from the rafts. Syntaxin 4 in
activated macrophages localized to discrete cholesterol-dependent
puncta on the plasmamembrane, particularly on filopodia. Imaging
the early stages of TNF surface distribution revealed these puncta
to be the initial points of TNF delivery. During the early stages of
phagocytosis, syntaxin 4 was recruited to the phagocytic cup in a
cholesterol-dependent manner. Insertion of VAMP3-positive recy-
cling endosome membrane is required for efficient ingestion of a
pathogen.Without this recruitment of syntaxin 4, it is not incorpo-
rated into the plasma membrane, and phagocytosis is greatly
reduced. Thus, relocation of syntaxin 4 into lipid rafts in macro-
phages is a critical and rate-limiting step in initiating an effective
immune response.
In response to pathogens, activated macrophages produce and
secrete tumor necrosis factor  (TNF),2 a proinflammatory cytokine
responsible for the activation and recruitment of cells necessary to
mount a successful immune response (1). Lipopolysaccharide (LPS), a
bacterial membrane component, is a potent activator of macrophages,
binding to the CD14-MD2-TLR4 complex at the surface (2) that signals
the induction of widespread gene transcription, including that of TNF
(3, 4). This ensures the rapid and abundant synthesis of the 26-kDa
transmembrane form of TNF, which initially accumulates in the Golgi
complex (5) and is then trafficked to the cell surface for proteolytic
cleavage by the TNF-converting enzyme (TACE) (6). We have shown
recently that TNF is transported from the trans-Golgi network to the
recycling endosome and is then delivered to the cell surface via fusion of
the recycling endosome membrane at the site of the phagocytic cup
formation (7, 8). Two distinct steps of membrane fusion are therefore
required during the post-Golgi transport of TNF.
Membrane fusionofTNF transport vesicles ismediatedbymembersof
the solubleN-ethylmaleimide-sensitive factor attachment protein receptor
(SNARE) protein family (7, 8). Cognate pairing of an R-SNARE (generally
on the vesicle) and a Q-SNARE complex (generally on the target mem-
brane) is necessary at each trafficking step for specificity in vesicle docking
andmembrane fusion (9, 10). A variety of SNARE proteins is expressed in
macrophages. The trans-Golgi Q-SNARE complex of syntaxin 6/syntaxin
7/Vti1b pairs with VAMP3 on the recycling endosome in the first step of
post-Golgi transport of TNF. Next theVAMP3 pairs with the cell surface
Q-SNARE complex of syntaxin 4/SNAP-23 for TNF delivery to the cell
surface (7, 8, 11). Syntaxin 4, syntaxin 6, Vti1b, SNAP-23, and VAMP3 are
up-regulatedduringLPS activation to accommodate the increased traffick-
ing during TNF secretion (7, 8, 11). During phagocytosis, the Q-SNARE
syntaxin 4 concentrates at the phagocytic cup to mediate fusion of the
recycling endosome, providing excess membrane for microorganism
engulfmentandrapidlydeliveringTNF to thecell surface for secretion (7).
Lipid rafts, specific membrane microdomains that are enriched in
sterols and sphingolipids, play a number of important roles in immune
cells; for instance, they contribute to B cell receptor signaling and anti-
gen uptake (12, 13), ligand-mediated signaling from the T cell receptors
(14, 15) and high affinity IgE receptors (16), and play a role in MHCII-
mediated antigen presentation (17, 18). In macrophages, phagosomes
are enriched in raft proteins (19–21). In other cell types lipid rafts have
been shown to organize and regulate SNARE proteins (22, 23).We thus
investigated a possible role for lipid rafts in SNARE-mediated delivery of
TNF to the cell surface.We show here that an inducible association of
syntaxin 4 with lipid rafts and a cholesterol-rich membrane environ-
ment at specific exit sites are required for TNF secretion.
EXPERIMENTAL PROCEDURES
Antibodies and Reagents—Rabbit polyclonal and rat monoclonal anti-
mouse TNF antibodies were purchased from Calbiochem and Auspep
(Victoria, Australia), respectively. Anti-SNAP-23 and VAMP2 antibodies
were purchased from Synaptic Systems (Goettingen, Germany); anti-
Gi-3 antibodies were purchased from DuPont, and antibodies specific
for flotillin and syntaxin 6 were purchased from BD Biosciences. Anti-
bodies specific for TACE were purchased from Chemicon (Temecula,
CA), and anti-VAMP3 antibodies were purchased from Abcam (Cam-
bridge, UK). Alexa-488 or Alexa-647 conjugated to phalloidin to label
F-actin was from Molecular Probes (Eugene, OR), and filipin III was
purchased from Sigma. Anti-actin antibody was a gift from Peter Gun-
ning (Children’s Hospital at Westmead, Sydney, Australia), and anti-
bodies specific for syntaxin 4 and Munc18c were the kind gifts from
David James (Garvan Institute of Medical Research, Sydney, Australia).
Candida albicanswas kindly provided by Robert Ashman (University of
Queensland, Brisbane, Australia).
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Cell Culture, Activation, and Cholesterol Depletion—RAW264.7 mu-
rine macrophages were grown in RPMI 1640 medium with 10% serum
supreme and 1% L-glutamine as described previously (24). Cells were
activated with 100 ng/ml LPS (Salmonella minnesota Re 595, Sigma) in
the presence or absence of TACE inhibitor (BB-3103, British Biotech
Pharmaceuticals). For cholesterol depletion, cells were incubated for
15–30 min in 7.5 mM methyl--cyclodextrin (MCD) (Sigma) in
serum-free RPMI 1640.
Phagocytosis—In some experiments macrophages were primed for
18 h in the presence of 500 pg/ml IFN (R & D Systems) prior to their
incubation with liveC. albicans at a ratio of 10:1 (yeast:macrophage) for
10–40 min as described previously (7).
Sucrose Density Gradient Separation—Sucrose density gradient sep-
aration of membrane extracts was performed according to published
protocols (25). Briefly, macrophages were lysed by 20 passages through
a 27-gauge needle in homogenization buffer (10 mM Tris, pH 7.5, 150
mM NaCl, 5 mM EDTA) containing either 0.2 or 1% Triton X-100, and
the lysate was centrifuged at 2000 g for 2 min at 4 °C to pellet unbro-
ken cells and nuclei. The supernatant was loaded onto a 45 to 5% dis-
continuous sucrose gradient and centrifuged at 200,000 g in a TLS-55
rotor at 4 °C for 18 h. Eleven fractions (150 l) were collected from the
top of the gradient, plus an additional fraction of 600l representing the
load fraction. Samples were subjected to SDS-PAGE separation and
analyzed by immunoblotting as described previously (5).
Immunofluorescence Staining—Immunofluorescence staining was
performed as described previously (5). In some experiments cells grown
on coverslips were partially air-dried, and the apical membranes were
removed by application (30 s) and removal of damp filter paper (Milli-
pore) (26). The remaining adherent plasma membrane and cell frag-
ments were fixed and immunostained. Cholesterol in cell membranes
was stained using 250 g/ml filipin III in phosphate-buffered saline
containing 0.5% bovine serum albumin. Epifluorescence microscopy
was performed using an Olympus Provis AX70 microscope equipped
with a 100 oil objective and MTI digital camera and NIH Image soft-
ware. Confocal microscopy was performed using an LSM 510 META
(Carl Zeiss Microscope Systems). Three-dimensional reconstructions
were generated using LSM 510 META software.
Assays for TNF Trafficking and Secretion—The trafficking of TNF
from the Golgi complex to the cell surface was measured as described
previously using an immunofluorescence-based assay (11). To deter-
mine levels of secreted TNF, a commercial enzyme-linked immuno-
absorbent assay kit (OptEIA, BD Biosciences) was used according to the
manufacturer’s instructions.
RESULTS
SNARE Recruitment to Lipid Rafts—Cholesterol-rich membrane
domains and their associated proteins, typically insoluble in nonionic
detergents, can be isolated by flotation on sucrose density gradients
(27). Macrophage membranes extracted with 1% Triton X-100 were
investigated by sucrose density gradient separation and immunoblot-
ting to analyze the distribution of SNARE proteins involved in TNF
secretion (Fig. 1,A and B). Cholesterol-rich lipid raft domains (fractions
5–8) were characterized by the enrichment of known raft marker pro-
teins flotillin (25, 28) and the heterotrimericGi-3 subunit (29) (Fig. 1A).
The cell surface Q-SNARE protein SNAP-23 distributed throughout
both raft and nonraft fractions, although its Q-SNARE partner syntaxin
4 was recovered almost entirely in nonraft fractions (Fig. 1A). Munc18c,
a protein known to bind and regulate syntaxin 4 (30), also partitioned in
nonraft fractions (Fig. 1A). The trans-Golgi Q-SNARE syntaxin 6 (8)
segregated into nonraft fractions, although the R-SNAREs VAMP2 and
VAMP3 were detected in discrete fractions from both raft and nonraft
fractions (Fig. 1A).
LPS activation of macrophages induces increased expression of syn-
taxin 4 (11) and initiates a 4-fold recruitment of syntaxin 4 to raft
domains, resulting in over 40% of cellular syntaxin 4 now being concen-
trated in lipid rafts (Fig. 1, B and C). The distributions of other proteins
analyzed were unchanged after LPS activation (Fig. 1, B and C). Thus,
the differential distributions of the Q-SNARE components SNAP-23
and syntaxin 4 in lipid raft domains and the LPS-induced recruitment of
syntaxin 4 to rafts may represent a mechanism for modulating vesicle-
mediated delivery to the cell surface during TNF secretion.
Syntaxin 4 Localizes to Cholesterol-dependent Puncta with LPS Activa-
tion—We next examined the distribution of syntaxin 4 on the plasma
membrane by immunostaining. Because SNARE proteins are typically
on the cytoplasmic face of the plasma membrane, staining was per-
formed on patches of ripped open cells exposing the cytoplasmic face of
the plasmamembrane (26). Staining of F-actin provided orientation for
identifying and viewing cell patches. Prior to macrophage activation,
syntaxin 4 was localized to distinct puncta (0.5–1 m diameter) ran-
domly distributed on the cytoplasmic face of the plasmamembrane (Fig.
2A). Upon macrophage activation, syntaxin 4-stained puncta on the
main cell body increased in size (1–2m), whereas smaller syntaxin 4
puncta (less than 500 nm) also appeared de novo on filopodia (Fig. 2B).
Treatment of cells with MCD depletes cholesterol from cell mem-
branes disrupting cholesterol-dependent lipid raft domains (31, 32).
Cholesterol depletion with MCD resulted in a significant loss of syn-
taxin 4 puncta from the cell body in activated cells and a complete loss of
small syntaxin 4 puncta on filopodia (Fig. 2C). Disruption of cholesterol
withMCD in LPS-activated macrophages also resulted in depletion of
syntaxin 4, and the raft markers flotillin and Gi-3 from sucrose density
FIGURE 1. Syntaxin 4 recruitment to cholesterol-rich lipid raft fractions. A, unstimu-
lated RAW264.7 macrophages lysed in buffer containing 1% Triton X-100 were fraction-
atedbydiscontinuous sucrosedensity gradient centrifugation. Fractions 1–12were ana-
lyzedby immunoblotting. Lipid raft fractions 5–8 are denotedby thepresenceof the raft
markers flotillin and Gi-3. Individual SNARE proteins fractionate in lipid raft and/or non-
raft fractions. B, macrophages activated with LPS were extracted and fractionated as
above.C, bar chart, withmeans S.E. (n4), shows the relative amounts of eachprotein
in lipid raft fractions before andafter cell activation; of note is the recruitment of syntaxin
4 to lipid rafts upon activation.
Lipid Raft-mediated Cytokine Secretion
11950 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 281•NUMBER 17•APRIL 28, 2006
 at UQ Library on October 10, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
gradient fractions corresponding to lipid rafts (Fig. 2D). Thus, syntaxin
4, the SNARE responsible for TNF surface delivery, is found in cho-
lesterol-dependent clusters corresponding to lipid rafts at the plasma
membrane. The increased number and size of syntaxin 4 clusters on
activated cells is consistent with LPS-induced recruitment of syntaxin 4
to lipid rafts.
Surface Delivery of TNF Is Cholesterol-dependent—Treatment of
LPS-activated macrophages with MCD revealed that secretion of
TNF, but not its synthesis, is cholesterol-dependent. Secretion of sol-
uble TNF, as measured by an enzyme-linked immunosorbent assay,
was greatly reduced (60%) after cholesterol depletion in activated cells
(Fig. 3A). This reduction in surface delivery of TNF was confirmed by
using an immunofluorescence-based assay that measures the transport
of newly synthesized TNF from the Golgi complex to the cell surface
(11). TNF is labeled on the surface of LPS-activatedmacrophages (Fig.
3B), although depletion of cholesterol effectively blocks this surface
delivery of TNF (Fig. 3B). LPS signaling through the CD14-MD2-
TLR4 complex occurs in lipid rafts, and pretreatment of monocytes
with MCD has been shown to inhibit TNF secretion (33); however,
the p38 and c-Jun N-terminal kinase signaling pathways are reportedly
initiated (34). Consistent with this, TNF staining is present at the level
of the Golgi complex, suggesting TNF surface delivery rather than its
synthesis is disrupted (Fig. 3C). In addition, depletion of cholesterol had
no effect on the total levels of TNF present in LPS-activated cells (Fig.
3D). Thus, disruption of cholesterol-dependent lipid rafts effectively
reduced TNF secretion by blocking its surface delivery, without affect-
ing earlier steps in its synthesis or trafficking.
Cholesterol-dependent Syntaxin 4 Puncta Represent the Delivery Sites
for TNF—Additional sucrose density experiments were performed
using 0.2% Triton X-100 (35), producing a cleaner separation of the raft
maker flotillin and again showing the LPS-induced recruitment of syn-
taxin 4 to lipid rafts (Fig. 4A). Activation of macrophages induced the
synthesis of full-length TNF, which accumulates in the presence of
FIGURE 3. Surface delivery of TNF is cholesterol-dependent. A, TNF secretion from
unstimulatedmacrophages, LPS-activatedmacrophages (2h), andLPS-activatedmacro-
phages (2 h) treatedwithMCD for the final 30minwas quantified by an enzyme-linked
immunosorbent assay. The results from three experiments are shown in the graph along
with the means S.E. B, macrophages were treated with LPS for 2 h in the presence of
TACE inhibitorwith orwithoutMCD for the final 30min and immunostained for surface
TNF. In the absence of MCD TNF was delivered to the surface of activated cells;
however, in cells treated with MCD surface delivery of TNF was greatly reduced. C,
macrophageswere treatedwith LPS for 2 h in the presence of TACE inhibitor withMCD
for the final 30min, fixed, permeabilized, and stained to detect intracellular TNF. TNF
is still being synthesized and is present in the Golgi complex. D, cell lysates from unacti-
vated macrophages, LPS-activated macrophages (1 h), and LPS-activated macrophages
with MCD for the final 30 min (LPSMCD) were analyzed by immunoblotting.
FIGURE 4. TNF is delivered to syntaxin 4 puncta on filopodia. A, macrophages incu-
bated in the absence or presence of with LPS for 2 h with TACE inhibitor were lysed in
buffer containing 0.2% Triton X-100, fractionated by discontinuous sucrose density gra-
dient centrifugation, and analyzed by immunoblotting. Lipid raft fractions 5–8 are
denoted by the presence of the raftmarker flotillin. B, macrophages stimulatedwith LPS
for 30min in the presence of TACE inhibitor were fixed and stained for syntaxin 4, TNF,
and F-actin. Three-dimensional reconstructed, surface-rendered, and pseudocolored
composite images show theoutline of the cell with F-actin staining (green), surface TNF
staining (red), and syntaxin 4 (white). Initial points of delivery of newly synthesized TNF
are concentrated on the surface of filopodia. TNF and syntaxin 4 staining are seen to
colocalize in adjacent images, both appearing at the same points and on the same sur-
face features (arrows).
FIGURE 2. Syntaxin 4 localization to cholesterol-dependent puncta. A, staining for
syntaxin 4 and F-actin was performed on patches of ripped open macrophages that
expose the cytoplasmic face of the plasmamembrane. At least 50 cells were analyzed in
each of three different experiments. Staining consistently showed syntaxin 4 in distinct
puncta; these were 0.5–1 m and distributed over the cell body. Bar, 10 m. B, macro-
phages were activated with LPS for 2 h and treated as above. Syntaxin 4 puncta of
increased size (1–2 m) appeared on the cell body, whereas many smaller puncta (less
than 500 nm) now appear especially on filopodia. C, macrophages were activated with
LPS for 2 h in the presence of MCD for the final 30 min and treated as above. The
syntaxin 4 puncta seen on macrophage cell body rip offs did not change size or appear
on filopodia in cholesterol-depleted cells. D, macrophages activated with LPS for 2 h in
the presence or absence of 1%MCD for the final 30minwere lysed in buffer containing
1% Triton X-100, fractionated by discontinuous sucrose density gradient centrifugation,
and analyzed by immunoblotting. Cholesterol depletion resulted in the loss of syntaxin
4 and raft marker proteins from lipid raft fractions 5–8.
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TACE inhibitor and is partially lipid raft-associated (Fig. 4A). Confocal
imaging was used to examine the relationship between syntaxin 4 and
newly synthesized TNF delivery to the cell surface. To capture and
stain TNF at the surface, its proteolytic release was prevented by using
a TACE inhibitor, and the external aspect of the cell surface was imaged
on intact macrophages shortly after LPS activation. Three-dimensional
composite confocal images were enhanced by surface rendering to
remove background staining and reveal TNF surface staining (Fig. 4B).
Under these conditions, the earliest appearance of newly synthesized
TNF was observed in discrete patches on the macrophage surface.
TNF patches (Fig. 4B, red labeling) were notably concentrated on
filopodia where they colocalized with the syntaxin 4 puncta (Fig. 4B). At
later times (1–2 h), TNF staining becomes more widely spread across
the cell surface (data not shown and Fig. 3B), either because of addi-
tional delivery sites being recruited or because of retention and spread-
ing of uncleaved TNF. Thus, these syntaxin 4 patches correspond to
the cholesterol-dependent syntaxin 4 puncta labeled on filopodia in
ripped open cells and can now be pinpointed as the initial delivery sites
for TNF on the macrophage surface. Interestingly, TACE, the enzyme
responsible for cleaving TNF at the cell surface (6), is totally excluded
from lipid raft fractions (36) (Fig. 4A), suggesting that surface delivery
and TNF cleavage occur in different membrane domains.
Cholesterol Dependence of SNARE Accumulation and TNF Deli-
very to the Phagocytic Cup—During the phagocytosis of C. albicans,
TNF is delivered to the actin-rich phagocytic cup (7) (Fig. 5A) where
TACE also accumulates (7) (Fig. 5C). Disruption of cholesterol-depend-
ent lipid rafts inhibited TNF surface delivery to the phagocytic cup
without affecting TNF synthesis (Fig. 5B). Macrophages were stained
for cholesterol using filipin, which revealed the presence of cholesterol-
rich membrane domains in the phagocytic cups (Fig. 5D). Syntaxin 4
also concentrates in the cups (37) (Fig. 6A); however, depletion of cho-
lesterol ablated syntaxin 4 staining at the phagocytic cup (Fig. 6A). Like-
wise, staining of the cognate R-SNARE for TNF delivery, VAMP3,
which is normally enriched at the phagocytic cup (7, 38) (Fig. 6B), is
abolished by pretreatment of macrophages with MCD (Fig. 6B).
Thus, cholesterol-rich lipid rafts in the phagocytic cup are required for
the concentration of SNARE complexes necessary for TNF delivery at
this site.
The cholesterol-rich lipid rafts at the site of phagocytic cup formation
are also required for efficient phagocytosis of yeast. Treatment of cells
with MCD reduced the number of macrophages with internalized
yeast from60 to11%(Fig. 6C), confirming the importanceof cholesterol-
dependent lipid rafts in phagocytosis. This reinforces the dual function
of recycling endosome membrane delivery to the phagocytic cup for
both cytokine secretion and phagocytosis. Clustering of SNAREs in
cholesterol-rich lipid rafts at these sites permits the delivery of this
membrane for these innate immune functions.
DISCUSSION
We show here that upon macrophage activation, syntaxin 4, a
Q-SNARE responsible for the surface delivery of TNF, is recruited to
discrete cholesterol-dependent lipid rafts on the plasma membrane,
predominantly on filopodia, which then become the site of delivery for
FIGURE5.TNF is delivered tophagocytic cups ina cholesterol-dependentmanner.
A, IFN-primed macrophages incubated with C. albicans in the presence of TACE inhib-
itor for 15 min were stained for TNF and F-actin. Uncleaved TNF concentrates at the
phagocytic cup. Bar, 10m. B, IFN-primedmacrophages treatedwithMCD for 30min
were incubated with C. albicans in the presence of TACE inhibitor and stained for TNF
and F-actin. TNF no longer localizes to the phagocytic cup, although it is present at the
level of the Golgi complex. C, IFN-primed macrophages incubated with C. albicans for
20min were stained for TACE and F-actin. TACE localizes to the phagocytic cup.D, IFN-
primed macrophages incubated with C. albicans for 40 min were stained with filipin III
revealing the presence of cholesterol-rich membrane domains in the phagocytic cups.
FIGURE 6. Cholesterol-dependent localization of SNARE proteins at the phagocytic
cup.A, IFN-primedmacrophages incubated in the presence or absence ofMCD for 30
min prior to incubationwith C. albicanswere stained for syntaxin 4 and F-actin. Syntaxin
4 localization to the actin-rich phagocytic cup is dependent upon cholesterol. Bar, 10
m. B, IFN-primedmacrophages were treated as in A and stained for VAMP3 and F-ac-
tin. VAMP3 localization to the actin-rich phagocytic cup is dependent upon cholesterol.
C, IFN-primed macrophages incubated in the presence or absence of MCD prior to
incubationwith C. albicanswere stained for F-actin.Macrophageswere examined under
the microscope for the presence of internalized yeast. Bar chart, with the means S.E.,
shows the percentage of macrophages containing yeast. A minimum of 500 cells was
counted per condition.
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TNF. TACE, the enzyme responsible for cleavage of TNF at the cell
surface, is excluded from these raft domains suggesting that TNF is
translocated to other membrane subdomains prior to its cleavage. Dur-
ing the initial stages of phagocytosis, syntaxin 4 recruitment to lipid rafts
is concentrated at the phagocytic cup and is crucial for the delivery of
the excessmembrane required to engulf amicroorganism in addition to
the rapid delivery and secretion of TNF.
It has been suggested that spatial distribution of SNAREs in the
plasma membrane may play a prominent role in regulating exocytosis.
In other cell types (35, 39–42) a number of SNARE proteins are located
in cholesterol-dependent lipid raft domains. Previous studies in macro-
phages have shown that syntaxin 4 and SNAP-23 are also associated
with lipid rafts in these cells (21, 22). SNAREs display different levels of
raft association depending on the cell type (23); however, to date no
other cell type has shown the stimulus coupled relocation of SNARE
proteins into lipid rafts that we demonstrate occurs with syntaxin 4 in
LPS-activated macrophages. The precise role of lipid rafts in SNARE-
mediated fusion is currently unclear. The lipid rafts may act as sites for
transmembrane pairing and membrane fusion, or they may function in
a regulatory fashion by spatially separating the Q-SNARE partners in
the membrane until they are required for fusion. Consistent with lipid
rafts as fusion sites in PC12 cells (39, 41), neutrophils (43), synapto-
somes (44), and now macrophages, disruption of lipid rafts leads to a
decrease in secretion. In contrast, the decreased lipid raft association of
SNAP-23/25 increased the secretion of recombinant growth hormone
from PC12 cells (45) suggesting a more regulatory role for lipid rafts in
this case. There are of course many other examples of molecules being
recruited to lipid rafts in immune cells. The relocation of receptors for
antibody complex or antibody inB cells, T cells,mast cells, and basophils to
lipid rafts coordinates signaling (46).
The Sec/Munc18 family of SNARE-binding proteins regulates SNARE
complex formation, and because in macrophages Munc18c is completely
excluded from raft domains, it may function to restrict the movement of
syntaxin 4 into lipid rafts for SNARE complex formation (47, 48). Similar
results are seen in mast cells where syntaxin 3/Munc18b complexes were
found in nonraft fractions, whereas syntaxin 3-containing SNARE com-
plexes were found within lipid rafts domains (49). Lipid rafts may also
orchestrate the fateandbiological activitiesofTNF.TNFcanberetained
on cells as an active 26-kDa transmembrane protein at the cell surface,
otherwise it is cleaved by the enzyme TACE and released as a soluble
17-kDa cytokine for other roles in immunity (50–52).We found TACE in
nonraft fractions regardless of the activation state of the macrophages,
implying that TNF must first exit the lipid raft domains in order to be
cleaved and released from themembrane, although this remains to be for-
mally shown. Retaining TNF in lipid rafts could potentially preserve the
26-kDa transmembrane format the surface, and the release from lipid rafts
would allow cleavage and release of the 17-kDa form, thus dictating the
physiological functions of TNF.
Upon activation, macrophages assume a highly ruffled cell surface
with the extension of exaggerated filopodia (53) rich in cholesterol and
lipid rafts (54). We now show syntaxin 4 in resting macrophages local-
izes to discrete puncta mainly on the cell body similar to the syntaxin 1
cholesterol-dependent puncta found in neuroendocrine cells (41) and
the punctate staining of SNAP-23 on adipocytes (35). Upon activation,
additional cholesterol-dependent syntaxin 4 puncta appear on the sur-
face, particularly on filopodia forming the sites for the initial delivery of
TNF. Larger cholesterol-dependent clusters also emerge on the sur-
face ofmacrophages after LPS activation, the significance ofwhich is not
yet clear. Individual lipid raft microdomains are typically below 50 nm
diameter (55, 56), and TNF delivery occurs at the many smaller syntaxin
4-labeled clusters; nevertheless, raft clustering has been demonstrated at
sites of T cell receptor stimulation during T cell activation (57).
The formation of preferential fusion sites on filopodia is important in
the context of macrophages where excess membrane is required for the
formation of the nascent phagocytic cup (58, 59). We have recently
shown the delivery of recycling endosomemembrane containing TNF
to the nascent phagocytic cup serves to provide extra membranes to
engulf a microbe while simultaneously delivering TNF to surface
delivery for rapid secretion (7). The relocation of syntaxin 4 to lipid rafts
in the phagocytic cup ensures the recycling endosome and its cargo
TNF are delivered to these specific sites. Efficient phagocytosis of par-
ticles, such as mycobacteria, opsonized red blood cells, and now yeast,
requires cholesterol (20, 60). Our data suggest this reliance on choles-
terol is because of the requirement of SNAREs to be associated with
lipid rafts for delivery of extra membrane to the phagocytic cup.
The family of serumcholesterol-reducing drugs termed statins (3-hy-
droxy-3-methylglutaryl-coenzyme A reductase inhibitors) has been
reported to have anti-inflammatory properties, such as reducing induc-
ible nitric-oxide synthase and proinflammatory cytokines, including
TNF, inmacrophages treatedwith lovastatin (61–64). However, other
reports show that statins can increase the pro-inflammatory response;
for example, simvastatin can increase the promoter activity and produc-
tion of IL-12p40 and TNF in macrophages (65–67). How the require-
ment of cholesterol for the delivery to the cell surface of cytokines is
involved in the statin influence on inflammatory response has yet to be
determined.
In conclusion, the data presented here show that the delivery of
TNF to the plasma membrane in LPS-activated and phagocytosing
macrophages is dependent upon the movement of syntaxin 4 into
cholesterol-dependent lipid rafts to be fusion-competent. Our findings
are in keeping with the participation of lipid rafts in forming surface
delivery and exit sites for cytokine secretion.
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